GlassScriptPhysician profile
Michael Y Shy
NPI 1396067609
$1,882.61
in general payments reported to CMS, 2019-2025
13 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $27.72 · 2021: $170 · 2022: $14.14 · 2023: $191 · 2024: $227 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.42 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $817.74 | 2019-2025 | Moses, General - Erectile Dysfunction, Ams 700 |
| Astellas Pharma US INC | $252.13 | 2019-2025 | |
| Coloplast Corp | $156.84 | 2024 | |
| Olympus America INC. | $150.00 | 2023 | Itind System |
| Richard Wolf Medical Instruments Corp. | $145.85 | 2019 | |
| Pfizer INC. | $124.00 | 2019-2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.87 | 2023 | Xifaxan |
| Sumitomo Pharma America, INC. | $26.95 | 2024 | Orgovyx |
| Blue Earth Diagnostics | $23.62 | 2021 | |
| Verity Pharmaceuticals INC. | $16.90 | 2024 | Trelstar |
| Myovant Sciences INC. | $14.14 | 2022 | |
| Supernus Pharmaceuticals, INC. | $13.57 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.